Fred
LaPlant
Corporate
Analytical Spectroscopy Group,
3M
Dr.
Fred LaPlant received his B.S. in chemistry from San Diego State University
and his PhD in analytical
chemistry from Purdue. He has 15
years experience in the area of process monitoring and control, most
recently in Pfizer Global R&D. He is currently in the Corporate
Analytical Spectroscopy group at 3M.
Analytical Seminar Series: Spectroscopic
Tools for Process Analysis of Pharmaceutical Products The pharmaceutical industry has historically been extremely inefficient in manufacturing products. Constrained by government regulation and buoyed by high profit margins, manufacturing efficiency often took a back seat to regulatory conservatism and releasing product to market faster. Recently the FDA and industry have begun partnering to bring a risk-based approach to manufacturing validation, a key component of which is on-line process understanding using Process Analytical Technology (PAT). Analytical spectroscopy plays a key role in many of these applications. This talk will give an overview of pharmaceutical unit operations and the tools that can be used to provide information at each step in the manufacturing process. Special emphasis will be placed on chemical imaging and the potential benefits of visualizing the complete distribution of components in solid dosage forms. |